Richard A. Spritz, MD, Professor and Director Human Medical Genetics and Genomics Program University of Colorado, School of Medicine, is one of the world’s leading vitiligo researchers. He has been conducting groundbreaking work and understanding the genetics behind vitiligo for nearly 20 years. This path led to discovery of 23 genes linked to susceptibility for vitiligo and other previously unseen correlations in 2017. Study results were published in Nature Genetics and boosted interest of many pharmaceutical compaines in this previously "neglected disease."
Much more research would be needed before a drug could be developed, and then it would have to go through rounds of safety and efficacy testing. Spritz said enough work has been done that complex relationships between genes “are coming together in a way that kind of makes sense,” which has allowed vitiligo researchers to “leap frog” ahead faster than Spritz expected.
An accomplished mountain climber, ski instructor and a race driver, now in his late 60's, Richard keeps on pushing limits in his life. Celebration of semi-retirement of Prof. Richard Spritz will be held at Anschutz Medical Campus on Thursday, May 9th at 4:00 PM. For those who won't be in the Denver area, tune in via Zoom to see his talk on wandering in the genomic wilderness of vitiligo.
- What is vitiligo?
Vitiligo (pronounced vit-ill-EYE-go) is a relatively common skin disease characterized by smooth, white, painless spots or patches on various parts of the body and hairs above i...
- Who is prone to vitiligo?
Scientists know that some people are genetically predisposed to a specific group of autoimmune diseases – including generalized vitiligo – but do not know who and why.It doesn’t...
- Polypodium leucotomos as an adjunct treatment for vitiligo?
Extracts of the tropical fern Polypodium leucotomos appear to have beneficial properties for the vitiligious skin. Polypodium leucotomos (also classified as Polypodium aureum) a...
Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.Copyright (C) Bodolóczki Júlia
By taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.